InvestorsHub Logo
Followers 22
Posts 3625
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Saturday, 11/06/2021 6:56:53 AM

Saturday, November 06, 2021 6:56:53 AM

Post# of 166
Collegium Pharmaceutical price target lowered to $26 from $28 at H.C. Wainwright

H.C. Wainwright analyst Oren Livnat lowered the firm's price target on Collegium Pharmaceutical to $26 from $28 and keeps a Buy rating on the shares. The analyst sees Xtampza 20022 return to growth likely, with potential 2023 accelerations if contracts improved. Livnat added that COVID-related mix shift worsened in Q3, and that "all eyes" are now on the company's 2022 guidance and execution.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COLL News